Boston Scientific (BSX) Tax Provisions (2009 - 2026)

Boston Scientific has disclosed Tax Provisions across 18 years of filings, most recently posting $155.0 million for Q2 2026.

• In Q2 2026, Tax Provisions rose 6.16% year-over-year to $155.0 million; the TTM figure through Jun 2026 stood at $192.0 million (down 61.75% YoY), while the FY2025 annual figure was $493.0 million, up 13.07% from the prior year.
• Tax Provisions came in at $155.0 million for Q2 2026 at Boston Scientific, up from -$176.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $255.0 million in Q4 2022 to a low of -$176.0 million in Q1 2026.
• Average Tax Provisions over 5 years is $96.8 million, with a median of $110.0 million recorded in 2023.
• Year-over-year, Tax Provisions surged 2200.0% in 2024 and sank 232.33% in 2026.
• Over 5 years, Tax Provisions stood at $255.0 million in 2022, then tumbled by 99.61% to $1.0 million in 2023, then surged by 2200.0% to $23.0 million in 2024, then jumped by 30.43% to $30.0 million in 2025, then soared by 416.67% to $155.0 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $155.0 million in Q2 2026, -$176.0 million in Q1 2026, and $30.0 million in Q4 2025.